The occurrence of varicella after zoster vaccination in a patient with rheumatoid arthritis receiving tofacitinib

被引：0
|
作者：
Kao, Chung-Mao [1 ]
Hsieh, Tsu-Yi [1 ]
Lai, Kuo-Lung [1 ]
机构：
[1] Taichung Vet Gen Hosp, Dept Internal Med, Div Allergy Immunol & Rheumatol, Taichung 40705, Taiwan
来源：
ARCHIVES OF RHEUMATOLOGY | 2021年 / 36卷 / 02期
关键词：
D O I：
10.46497/ArchRheumatol.2021.8212
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：305 / 307
页数：3
相关论文
共 50 条
  • [31] Benefit and Risk of Tofacitinib in the Treatment of Rheumatoid Arthritis: A Focus on Herpes Zoster
    Yamaoka, Kunihiro
    DRUG SAFETY, 2016, 39 (09) : 823 - 840
  • [32] Benefit and Risk of Tofacitinib in the Treatment of Rheumatoid Arthritis: A Focus on Herpes Zoster
    Kunihiro Yamaoka
    Drug Safety, 2016, 39 : 823 - 840
  • [33] THE RISK OF ZOSTER AFTER VARICELLA VACCINATION IN CHILDREN WITH LEUKEMIA
    LAWRENCE, R
    GERSHON, AA
    HOLZMAN, R
    STEINBERG, SP
    NEW ENGLAND JOURNAL OF MEDICINE, 1988, 318 (09): : 543 - 548
  • [34] Evaluate the risk of cardiovascular event in rheumatoid arthritis patient receiving tofacitinib and TNF inhibitors in Taiwan
    Shen, Chin-Yao
    Lai, Edward
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 278 - 279
  • [35] Unintentional Monotherapy in Rheumatoid Arthritis Patients Receiving Tofacitinib and Drug Survival Rate of Tofacitinib
    Inanc, Nevsun
    Abacar, Kerem Y.
    Ozturk, Mehmet A.
    Tufan, Abdurrahman
    Karadeniz, Hazan
    Sari, Ismail
    Can, Gercek
    Erez, Yesim
    Pehlivan, Yavuz
    Dalkilic, Huseyin E.
    Ocak, Tugba
    Cefle, Ayse
    Yazici, Ayten
    Senel, Abdurrahman S.
    Akar, Servet
    Durak-Ediboglu, Elif
    Koca, Suleyman S.
    Piskin-Sagir, Rabia
    Yilmaz, Sema
    Gulcemal, Semral
    Soysal-Gunduz, Ozgul
    Basibuyuk, Canberk S.
    Alkan, Serdar
    Cesur, Teoman Y.
    Onen, Fatos
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2023, 29 (08) : 365 - 369
  • [36] UNINTENTIONAL MONOTHERAPY IN RHEUMATOID ARTHRITIS PATIENTS RECEIVING TOFACITINIB AND DRUG SURVIVAL RATE OF TOFACITINIB
    Inanc, N.
    Abacar, K.
    Ozturk, M. A.
    Tufan, A.
    Karadeniz, H.
    Sari, I.
    Can, G.
    Erez, Y.
    Pehlivan, Y.
    Dalkilic, E.
    Ocak, T.
    Cefle, A.
    Yazici, A.
    Senel, A.
    Akar, S.
    Ediboglu, E. Durak
    Koca, S. S.
    Sagir, R. Piskin
    Yilmaz, S.
    Gulcemal, S.
    Gunduz, O. Soysal
    Basibuyuk, C. S.
    Alkan, S.
    Cesur, T. Y.
    Onen, F.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1338 - 1338
  • [37] The Safety and Immunogenicity of Live Zoster Vaccination in Patients With Rheumatoid Arthritis Before Starting Tofacitinib: A Randomized Phase II Trial
    Winthrop, Kevin L.
    Wouters, Ann G.
    Choy, Ernest H.
    Soma, Koshika
    Hodge, Jennifer A.
    Nduaka, Chudy I.
    Biswas, Pinaki
    Needle, Elie
    Passador, Sherry
    Mojcik, Christopher F.
    Rigby, William F.
    ARTHRITIS & RHEUMATOLOGY, 2017, 69 (10) : 1969 - 1977
  • [38] Optic neuropathy after influenza vaccination in a patient with rheumatoid arthritis
    Tzoukeva, A.
    Deleva, N.
    Kaprelyan, A.
    EUROPEAN JOURNAL OF NEUROLOGY, 2010, 17 : 565 - 565
  • [39] Enterococcal Pyomyositis in a Patient of Rheumatoid Arthritis on Tofacitinib and Methotrexate
    Dixit, Juhi
    Agarwal, Vikas
    Rathore, Upendra
    INDIAN JOURNAL OF RHEUMATOLOGY, 2024,
  • [40] Tofacitinib Induced Psoriasiform Lesion in a Patient With Rheumatoid Arthritis
    Erol, Kemal
    Ertas, Rapp
    ARCHIVES OF RHEUMATOLOGY, 2020, 35 (03) : 440 - 442
12345